Methods and compositions for treating and diagnosing disease
Methods and compositions for diagnosing and treating diseases, particularly cancer, associated with differential expression of cancer-associated targets (CAT) in disease cells compared to healthy cells are provided. Also provided are antagonists and agonists of CAT, and methods for screening agents that modulate CAT level or activity in vivo or in vitro.
1. A method of diagnosing lung cancer in a subject, the method comprising detecting a higher level of Na-K ATPase beta3 protein in a sample from the subject's lung as compared to the level of Na-K ATPase beta3 protein in samples from healthy subject's lungs, wherein the higher level of Na-K ATPase beta3 protein indicates that said subject has lung cancer, and wherein the amino acid sequence of the Na-K ATPase beta3 protein comprises a sequence selected from group consisting of SEQ ID NOS:127-134.
2. The method of claim 1 , wherein the higher level of Na-K ATPase beta3 protein is detected by contacting the sample with an isolated antibody that selectively binds to the Na-K ATPase beta3 protein and determining the extent of binding of the antibody to the Na-K ATPase beta3 protein.
3. The method of claim 2 , wherein the antibody is coupled to a detectable substance.